GO:0061042 vascular wound healing: Angiogenesis-Driven Vascular Repair, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061042 vascular wound healing describes the biological process in which new blood vessels sprout from pre-existing vessels and restore the integrity of damaged vasculature.
• The process is driven primarily by VEGF signaling, which activates endothelial proliferation, migration, and tube formation during repair.
• Impaired vascular wound healing is a hallmark of diabetic wounds, where compromised angiogenesis and vascular integrity delay closure.
• Chemokines orchestrate the recruitment of endothelial progenitors and inflammatory cells that support vessel regrowth in wounds.
• Sustained oxygenation and VEGF-mediated interventions accelerate vascular wound healing in preclinical diabetic models.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of genes such as VEGFA, HIF1A, and CXCL12 in vascular repair.
Description
Vascular wound healing (GO:0061042) is the biological process by which new blood vessels emerge from the proliferation of pre-existing vessels and contribute to restoring integrity to damaged vasculature. This process is essential after tissue injury because the re-establishment of a functional microcirculation delivers oxygen, nutrients, and immune cells to the wound bed while removing metabolic waste. Without adequate vascular wound healing, wounds become chronic, as observed in diabetic ulcers where angiogenesis and vascular integrity are compromised. The term is therefore central to regenerative biology, vascular medicine, and the development of pro-angiogenic therapeutics. Researchers study GO:0061042 to identify molecular drivers of endothelial sprouting, to model impaired repair in disease, and to evaluate CRISPR-based interventions that modulate vessel regrowth. Because vascular wound healing intersects with inflammation, coagulation, and extracellular matrix remodeling, it serves as an integrative endpoint for both mechanistic and translational studies.
vascular wound healing At A Glance
| GO ID | GO:0061042 |
|---|---|
| GO term | vascular wound healing |
| Ontology | biological_process |
| Synonym | none |
| Major function | Restoration of vascular integrity through angiogenesis from pre-existing vessels |
| Related process | Angiogenesis, endothelial cell proliferation, wound healing |
| Cellular players | Endothelial cells, pericytes, inflammatory cells, progenitor cells |
| Key signaling | VEGF, chemokine, and hypoxia-driven pathways |
| Disease relevance | Diabetic wound healing, chronic ulcers, ischemic injury |
What Is GO:0061042?
According to the Gene Ontology, vascular wound healing (GO:0061042) is the blood vessel formation process in which new vessels arise from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature. In practical terms, it covers the sprouting, migration, and stabilization of endothelial cells that rebuild a damaged vascular network after injury, rather than the initial hemostatic plug alone.
Why Is vascular wound healing Important in Cell Biology?
Vascular wound healing is important because it determines whether injured tissue receives sufficient perfusion to support repair, and its failure underlies chronic non-healing wounds such as diabetic ulcers. Understanding GO:0061042 helps researchers identify therapeutic targets that promote angiogenesis, restore vascular integrity, and improve outcomes in ischemic and metabolic disease.
• Provides the microcirculation required for oxygen and nutrient delivery to healing tissue.
• Failure of vascular wound healing contributes to chronic diabetic ulcers.
• VEGF signaling is a central driver of endothelial sprouting during repair.
• Chemokines coordinate leukocyte and progenitor recruitment to the wound.
• Sustained oxygenation accelerates epithelialization and angiogenesis in wounds.
• Heparanase procoagulant domain influences bleeding and wound healing.
• Curcumol promotes VEGF-mediated diabetic wound healing in vivo.
• Therapeutic angiogenesis strategies aim to enhance wound vascularization.
• Tendinopathy research highlights vascular insufficiency in connective tissue repair.
• CRISPR models allow causal dissection of genes controlling vessel regrowth.
What Happens During vascular wound healing?
Initiation by injury and hypoxia
In simple terms: When tissue is injured, low oxygen triggers signals that start new blood vessel growth.
Tissue injury disrupts existing vessels and creates a hypoxic microenvironment that stabilizes hypoxia-inducible factors and induces angiogenic cytokines. This hypoxic drive is a key initiator of vascular wound healing, linking metabolic stress to endothelial activation. In diabetic wounds, this initiation is blunted, contributing to impaired healing.
VEGF-driven endothelial activation
In simple terms: VEGF acts like a key that unlocks endothelial cells to multiply and move.
Vascular endothelial growth factor (VEGF) binds VEGFR2 on endothelial cells and activates proliferation, migration, and survival programs essential for sprouting angiogenesis. VEGF-mediated signaling is a central molecular mechanism of vascular wound healing, and its pharmacological enhancement improves diabetic wound repair in preclinical models. Sustained oxygenation further supports VEGF-driven angiogenesis during healing.
Chemokine-guided recruitment
In simple terms: Chemokines are chemical signals that call repair cells to the wound.
Chemokines such as CXCL12 recruit endothelial progenitor cells and inflammatory cells that support vessel regrowth and matrix remodeling. This chemokine network integrates immune and vascular arms of wound healing, and its dysregulation is associated with impaired repair.
Sprouting, lumen formation, and stabilization
In simple terms: Endothelial cells form new tubes and stabilize them into functional vessels.
Activated endothelial cells degrade basement membrane, migrate into the wound, and form lumens that are stabilized by pericytes and extracellular matrix. This step restores vascular integrity, the defining outcome of GO:0061042. Heparanase procoagulant activity has been implicated in bleeding and wound healing, linking coagulation to vascular repair.
Resolution and vascular integrity restoration
In simple terms: The new vessels mature and the wound regains a stable blood supply.
As healing progresses, new vessels are pruned and remodeled to match tissue demand, restoring barrier integrity and perfusion. In diabetic wounds, this resolution phase is defective, with compromised angiogenesis and vascular integrity. Therapeutic strategies aim to enhance this resolution to improve wound closure.
Key Genes Involved in GO:0061042 vascular wound healing
The following genes and proteins are experimentally implicated in vascular wound healing and related angiogenic repair processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Primary angiogenic growth factor driving endothelial proliferation and migration | Central target for pro-angiogenic therapy in wounds |
| VEGFR2 (KDR) | Endothelial receptor mediating VEGF signaling | Key node for sprouting angiogenesis assays |
| HIF1A | Hypoxia-inducible transcription factor inducing angiogenic genes | Links hypoxia to vascular wound healing |
| CXCL12 | Chemokine recruiting endothelial progenitors | Chemokine-guided vascular repair |
| CXCR4 | Receptor for CXCL12 on progenitor and endothelial cells | Progenitor recruitment in wound healing |
| HPSE | Heparanase with procoagulant domain | Bleeding and wound healing involvement |
| FGF2 | Fibroblast growth factor supporting angiogenesis | Therapeutic angiogenesis candidate |
| ANGPT1 | Angiopoietin stabilizing vessel maturation | Vascular integrity during repair |
| ANGPT2 | Angiopoietin promoting vessel destabilization and sprouting | Sprouting initiation in wounds |
| PECAM1 (CD31) | Endothelial junctional adhesion molecule | Endothelial marker for vessel quantification |
| CDH5 (VE-cadherin) | Endothelial adherens junction protein | Vascular integrity assessment |
| MMP2 | Matrix metalloproteinase remodeling basement membrane | Endothelial sprouting and matrix turnover |
| MMP9 | Matrix metalloproteinase in wound remodeling | Inflammation-linked vascular remodeling |
| NOS3 (eNOS) | Endothelial nitric oxide synthase | Vasodilation and endothelial function |
| TGFB1 | Cytokine modulating angiogenesis and fibrosis | Balancing vessel stabilization and scarring |
| IL6 | Inflammatory cytokine influencing angiogenesis | Inflammation-vascular crosstalk |
| TNF | Inflammatory cytokine modulating endothelial activation | Wound inflammation and vascular repair |
How Is vascular wound healing Regulated?
Vascular wound healing is regulated by a hierarchy of hypoxia-driven transcription, growth factor signaling, and chemokine gradients. HIF1A stabilization under low oxygen induces VEGFA and other angiogenic genes, while VEGF-VEGFR2 signaling controls endothelial proliferation and migration. Chemokines such as CXCL12 regulate progenitor recruitment and inflammatory cell trafficking to the wound. Coagulation-related factors, including the heparanase procoagulant domain, influence bleeding and wound healing, linking hemostasis to vascular repair. Therapeutic modulation of oxygenation further regulates the process, as sustained oxygen delivery accelerates angiogenesis and epithelialization.
vascular wound healing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VEGFA | Diabetic wound healing impairment | Streptozotocin-induced hyperglycemic rat model |
| HIF1A | Hypoxia-linked impaired wound angiogenesis | Sustained oxygenation wound model |
| PECAM1 | Compromised vascular integrity in diabetes | Diabetic wound tissue analysis |
| CXCL12 | Defective progenitor recruitment in chronic wounds | Chemokine knockout wound models |
| HPSE | Bleeding and wound healing disorders | Heparanase domain knockout models |
Diabetic wound healing impairment
Diabetic wounds exhibit compromised angiogenesis and vascular integrity, which contribute to delayed closure and chronic ulceration. VEGF-mediated signaling is impaired in hyperglycemic conditions, and interventions that restore VEGF activity improve wound healing in diabetic models. Sustained oxygenation also accelerates diabetic wound healing by promoting epithelialization and angiogenesis and decreasing inflammation.
Ischemic and chronic wounds
Insufficient vascular wound healing underlies chronic wounds of ischemic origin, where therapeutic angiogenesis strategies aim to enhance vessel regrowth. Chemokine dysregulation can further impair the recruitment of reparative cells, worsening tissue perfusion.
Connective tissue and tendon repair
Tendinopathy and related connective tissue injuries involve vascular insufficiency, and understanding vascular wound healing informs current concepts in basic science and clinical treatment. Coagulation and heparanase-related pathways also intersect with bleeding and wound healing in these contexts.
From vascular wound healing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is VEGFA required for wound angiogenesis? | Endothelial-specific VEGFA knockout |
| Does a point mutation in VEGFR2 alter sprouting? | VEGFR2 point-mutation knock-in |
| Can HIF1A stabilization rescue diabetic healing? | HIF1A overexpression or stabilized knock-in |
| How does CXCL12 guide progenitor recruitment? | CXCL12 tagged knock-in for lineage tracing |
| Does heparanase procoagulant domain affect wound healing? | HPSE domain knockout |
| Can therapeutic angiogenesis be enhanced? | Overexpression of angiogenic factors in wound models |
How to Study the vascular wound healing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Tube formation assay | Endothelial network formation in vitro | VEGF-driven angiogenesis assessment |
| Wound healing scratch assay | Endothelial migration capacity | Screening pro-angiogenic factors |
| Immunohistochemistry for PECAM1 | Vessel density in tissue | Diabetic wound vascular integrity |
| RNA sequencing | Transcriptional angiogenic signatures | Chemokine and growth factor profiling |
| Proteomics | Protein-level angiogenic mediators | Wound tissue analysis |
| Oxygen-controlled wound models | Effect of oxygenation on repair | Sustained oxygenation studies |
| Streptozotocin diabetic model | Impaired wound healing in vivo | VEGF-mediated healing studies |
Endothelial functional assays
Proliferation, migration, and tube formation assays measure the angiogenic capacity of endothelial cells under VEGF stimulation, providing direct readouts of vascular wound healing mechanisms.
In vivo wound healing models
Diabetic and ischemic wound models, including streptozotocin-induced hyperglycemic rats, allow assessment of angiogenesis, epithelialization, and inflammation during repair.
Imaging and histology
Immunostaining for endothelial markers such as PECAM1 and CDH5 quantifies vessel density and vascular integrity in wound tissue.
Molecular profiling
RNA sequencing and proteomics identify chemokine and growth factor signatures associated with successful or impaired vascular wound healing.
How CRISPR Can Be Used to Study GO:0061042 vascular wound healing
Knockout
CRISPR knockout of candidate genes such as VEGFA, HIF1A, or CXCL12 in endothelial cells or animal models enables causal testing of their requirement for vascular wound healing. Loss-of-function models reveal whether a gene is essential for sprouting, lumen formation, or vascular integrity.
Point Mutation
Point-mutation knock-in can model clinically relevant variants in receptors such as VEGFR2 or in signaling intermediates, allowing precise dissection of signaling nodes that control endothelial proliferation and migration during repair.
Knock-in
Tagged knock-in of genes like CXCL12 or PECAM1 supports lineage tracing and protein localization studies in wound tissue, clarifying how chemokine gradients guide progenitor recruitment.
Overexpression
Overexpression of angiogenic factors such as VEGFA or stabilized HIF1A can test whether enhancing a pathway accelerates vascular wound healing in diabetic or ischemic models.
How EDITGENE Supports vascular wound healing Research
Researchers studying vascular wound healing-related genes often need to determine whether a candidate gene is causally involved in endothelial sprouting, vessel stabilization, or restoration of vascular integrity. EDITGENE provides CRISPR-based cell and animal models that enable precise, reproducible interrogation of these mechanisms.
Contact EDITGENE today to design your custom CRISPR model for vascular wound healing research.
Frequently Asked Questions About vascular wound healing
What is vascular wound healing (GO:0061042)?
Vascular wound healing is the biological process in which new blood vessels form from pre-existing vessels and restore integrity to damaged vasculature.
What genes are involved in vascular wound healing?
Key genes include VEGFA, VEGFR2, HIF1A, CXCL12, CXCR4, HPSE, and endothelial markers such as PECAM1 and CDH5.
How does VEGF drive vascular wound healing?
VEGF binds VEGFR2 on endothelial cells and activates proliferation, migration, and survival programs that drive sprouting angiogenesis during repair.
Why is vascular wound healing impaired in diabetes?
Diabetic wounds show compromised angiogenesis and vascular integrity, and VEGF-mediated signaling is blunted under hyperglycemic conditions.
Can oxygenation improve vascular wound healing?
Sustained oxygenation accelerates diabetic wound healing by promoting epithelialization and angiogenesis and decreasing inflammation.
What role do chemokines play in wound vascularization?
Chemokines such as CXCL12 recruit endothelial progenitors and inflammatory cells that support vessel regrowth and matrix remodeling.
How is vascular wound healing studied experimentally?
Common methods include endothelial tube formation and migration assays, immunohistochemistry for vessel density, RNA sequencing, and in vivo diabetic wound models.
What CRISPR models are used to study vascular wound healing?
Knockout, point-mutation, knock-in, and overexpression models in endothelial cells and animals allow causal testing of candidate genes.
Is heparanase involved in wound healing?
The heparanase procoagulant domain has been implicated in bleeding and wound healing, linking coagulation to vascular repair.
What diseases involve defective vascular wound healing?
Diabetic ulcers, chronic ischemic wounds, and connective tissue injuries such as tendinopathy involve impaired vascular repair.
Conclusion
GO:0061042 vascular wound healing captures the angiogenesis-dependent restoration of damaged vasculature, a process driven by VEGF, hypoxia, and chemokine signaling. Its failure is central to diabetic and chronic wounds, making it a high-value target for therapeutic angiogenesis and CRISPR-based mechanistic studies. EDITGENE supports this research with knockout, point-mutation, knock-in, overexpression, and screening models tailored to vascular biology.
References
- 1. Guan Y et al.. 2021. Sustained oxygenation accelerates diabetic wound healing by promoting epithelialization and angiogenesis and decreasing inflammation.. Sci Adv 7(35) PMID: 34452918
- 2. Ahmad A et al.. 2022. Molecular mechanism of VEGF and its role in pathological angiogenesis.. J Cell Biochem 123(12):1938-1965 PMID: 36288574
- 3. Okonkwo UA et al.. 2020. Compromised angiogenesis and vascular Integrity in impaired diabetic wound healing.. PLoS One 15(4):e0231962 PMID: 32324828
- 4. Li HY et al.. 2016. Achilles Tendinopathy: Current Concepts about the Basic Science and Clinical Treatments.. Biomed Res Int 2016:6492597 PMID: 27885357
- 5. Crispel Y et al.. 2017. Involvement of the heparanase procoagulant domain in bleeding and wound healing.. J Thromb Haemost 15(7):1463-1472 PMID: 28439967
- 6. Ridiandries A et al.. 2018. The Role of Chemokines in Wound Healing.. Int J Mol Sci 19(10) PMID: 30340330
- 7. Veith AP et al.. 2019. Therapeutic strategies for enhancing angiogenesis in wound healing.. Adv Drug Deliv Rev 146:97-125 PMID: 30267742
- 8. Zhou J et al.. 2017. Curcumol Promotes Vascular Endothelial Growth Factor (VEGF)-Mediated Diabetic Wound Healing in Streptozotocin-Induced Hyperglycemic Rats.. Med Sci Monit 23:555-562 PMID: 28138126
